drugset / Trial / NCT00546611

The Purpose of This Study is to Determine Whether Topical Application of PEP005 is Safe for the Treatment of Common Wart(s)

NCT00546611

Phase 1 Withdrawn Peplin
NaSingle-groupOpen-labelTreatment

Summary

Verruca vulgaris, otherwise known as the common wart, is caused by the human papillomavirus (HPV). Common warts are generally located on the hands and feet, but can also occur elsewhere (e.g., any areas of frequent contact). Common warts have a characteristic cauliflower-like surface, are typically slightly raised above the surrounding skin and are generally diagnosed by visual inspection.The treatment of warts poses a therapeutic challenge for physicians. No single therapy has been proven effective at achieving complete remission in every patient.This study will aim to evaluate an up-to a three-day course of therapy with 0.05% PEP005 Topical Gel.

Timeline

Start
2007-10
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator ingenol mebutate Small molecule 0.05 % Topical

Indications